Skip to main content
Premium Trial:

Request an Annual Quote

IonGate, LIVC to Co-Develop, Market Ion Channel Screening Technology

NEW YORK (GenomeWeb News) - IonGate Biosciences and LIVC Technologies, both located in Frankfurt am Main, Germany, said today that they plan to co-develop and co-market LIVC’s technology for ion channel screening.
 
The technology, Light-Induced Voltage Clamp, uses light induction to measure voltage-activated ion channels. According to the companies, the method enables fast, high-throughput screening of voltage-activated ion channels and provides higher-quality data than current methods.
 
The companies said that the approach is applicable for finding new compounds that act directly on voltage-activated ion channels and determining their method of action.
 
IonGate specializes in transporter screening technology and markets the SURFE2R workstation. It was founded in 2000.
 
LIVC Technologies was founded earlier this year in order to commercialize the LIVC technology.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.